Scientists test Double-Punch cell therapy to fight tough cancers
NCT ID NCT07475182
Summary
This early study is testing a new two-part cell therapy for people with advanced solid cancers that have not responded to standard treatments. It combines two types of modified immune cells—dendritic cells and CAR-T cells—to try to help the immune system find and kill cancer cells more effectively. The main goal is to see if this combination is safe and shows early signs of working in a small group of 10 patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID CANCERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hainan Cancer Hospital
RECRUITINGHaikou, Hainan, 570311, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.